skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 456,991  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease
Material Type:
Article
Add to My Research

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S367-S367 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000776688.39678.45

Full text available

2
BIOM-59. NOVEL BIOMARKER DISCOVERY AND DIAGNOSTICS FOR INTRA-AXIAL BRAIN TUMORS, USING CSF PROTEOMICS
Material Type:
Article
Add to My Research

BIOM-59. NOVEL BIOMARKER DISCOVERY AND DIAGNOSTICS FOR INTRA-AXIAL BRAIN TUMORS, USING CSF PROTEOMICS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii18-vii18 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.069

Full text available

3
BIOM-17. SPYING ON GLIOMAS: LONGITUDINAL CSF AS A PLATFORM FOR GLIOMA MONITORING AND RESPONSE BIOMARKER DISCOVERY
Material Type:
Article
Add to My Research

BIOM-17. SPYING ON GLIOMAS: LONGITUDINAL CSF AS A PLATFORM FOR GLIOMA MONITORING AND RESPONSE BIOMARKER DISCOVERY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii7-vii7 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.027

Full text available

4
BIOM-11. ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER
Material Type:
Article
Add to My Research

BIOM-11. ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii6-vii6 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.021

Full text available

5
BIOM-50. THE IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF CIRCULAR RNA CIRC_63706 IN SONIC HEDGEHOG MEDULLOBLASTOMAS
Material Type:
Article
Add to My Research

BIOM-50. THE IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF CIRCULAR RNA CIRC_63706 IN SONIC HEDGEHOG MEDULLOBLASTOMAS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii16-vii16 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.060

Full text available

6
BIOM-35. A NEW PRECISION-MEDICINE APPROACH TO PREDICT TUMOR TREATMENT RESPONSE IDENTIFIES IN GLIOBLASTOMA A 17 GENE SIGNATURE PROGNOSTIC OF TMZ RESPONSE AND SURVIVAL WITH ROBUST PREDICTIVE VALUE
Material Type:
Article
Add to My Research

BIOM-35. A NEW PRECISION-MEDICINE APPROACH TO PREDICT TUMOR TREATMENT RESPONSE IDENTIFIES IN GLIOBLASTOMA A 17 GENE SIGNATURE PROGNOSTIC OF TMZ RESPONSE AND SURVIVAL WITH ROBUST PREDICTIVE VALUE

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii12 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.045

Full text available

7
BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBM
Material Type:
Article
Add to My Research

BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBM

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii15 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.057

Full text available

8
BIOM-16. A MULTI-OMIC, FUNCTIONAL PRECISION ONCOLOGY METHOD TO IDENTIFY RESPONSIVE GLIOBLASTOMA TUMOR CELLS AT SINGLE CELL RESOLUTION
Material Type:
Article
Add to My Research

BIOM-16. A MULTI-OMIC, FUNCTIONAL PRECISION ONCOLOGY METHOD TO IDENTIFY RESPONSIVE GLIOBLASTOMA TUMOR CELLS AT SINGLE CELL RESOLUTION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii7-vii7 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.026

Full text available

9
BIOM-33. TEMPORAL HETEROGENEITY OF DNA METHYLATION SUBCLASSES BETWEEN MATCHED NEWLY DIAGNOSED AND RECURRENT IDH-WILDTYPE GLIOBLASTOMA
Material Type:
Article
Add to My Research

BIOM-33. TEMPORAL HETEROGENEITY OF DNA METHYLATION SUBCLASSES BETWEEN MATCHED NEWLY DIAGNOSED AND RECURRENT IDH-WILDTYPE GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii11-vii11 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.043

Full text available

10
BIOM-60. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
Material Type:
Article
Add to My Research

BIOM-60. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii18-vii18 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.070

Full text available

11
BIOM-64. TARGETING IDENTIFICATION OF HOST-BRAIN CANCER SYSTEMIC CYTOKINE SIGNALLING FOR EARLY DETECTION AND TUMOUR SUB-TYPING
Material Type:
Article
Add to My Research

BIOM-64. TARGETING IDENTIFICATION OF HOST-BRAIN CANCER SYSTEMIC CYTOKINE SIGNALLING FOR EARLY DETECTION AND TUMOUR SUB-TYPING

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii19-vii19 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.074

Full text available

12
BIOM-31. TEMPOROSPATIAL PROTEIN PROFILING OF HUMAN GLIOBLASTOMAS REVEALS MOLECULAR MECHANISMS AND BIOMARKERS UNDERLYING RESPONSES TO IMMUNE CHECKPOINT INHIBITION
Material Type:
Article
Add to My Research

BIOM-31. TEMPOROSPATIAL PROTEIN PROFILING OF HUMAN GLIOBLASTOMAS REVEALS MOLECULAR MECHANISMS AND BIOMARKERS UNDERLYING RESPONSES TO IMMUNE CHECKPOINT INHIBITION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii11-vii11 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.041

Full text available

13
BIOM-29. THE PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PARTIAL MGMT PROMOTER METHYLATION FOR IDH-WILDTYPE GLIOBLASTOMA PATIENTS
Material Type:
Article
Add to My Research

BIOM-29. THE PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PARTIAL MGMT PROMOTER METHYLATION FOR IDH-WILDTYPE GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii10-vii10 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.039

Full text available

14
BIOM-36. A STUDY OF CLINICAL AND MOLECULAR PROGNOSTIC FACTORS FOR RESPONSE TO REGORAFENIB IN RECURRENT GLIOBLASTOMA
Material Type:
Article
Add to My Research

BIOM-36. A STUDY OF CLINICAL AND MOLECULAR PROGNOSTIC FACTORS FOR RESPONSE TO REGORAFENIB IN RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii12 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.046

Full text available

15
BIOM-24. TARGETED NEXT-GENERATION SEQUENCING (NGS) OF TEMPORALLY MATCHED CEREBROSPINAL FLUID (CSF) AND TUMOR TISSUE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
Material Type:
Article
Add to My Research

BIOM-24. TARGETED NEXT-GENERATION SEQUENCING (NGS) OF TEMPORALLY MATCHED CEREBROSPINAL FLUID (CSF) AND TUMOR TISSUE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii9-vii9 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.034

Full text available

16
BIOM-53. SPECIFIC MICRORNA EXPRESSION PATTERN PREDICTS RECURRENCE IN ATYPICAL MENINGIOMA
Material Type:
Article
Add to My Research

BIOM-53. SPECIFIC MICRORNA EXPRESSION PATTERN PREDICTS RECURRENCE IN ATYPICAL MENINGIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii16-vii17 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.063

Full text available

17
BIOM-38. TETRASPANIN 12 AS A TUMOR SUPPRESSOR AND BIOMARKER PREDICTING GOOD PROGNOSIS OF MALIGNANT GLIOMA
Material Type:
Article
Add to My Research

BIOM-38. TETRASPANIN 12 AS A TUMOR SUPPRESSOR AND BIOMARKER PREDICTING GOOD PROGNOSIS OF MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii13 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.048

Full text available

18
BIOM-06. IDENTIFICATION OF AN INFLAMMATORY BIOMARKER SIGNATURE IN PLASMA-DERIVED EXTRACELLULAR VESICLES OF GLIOBLASTOMA PATIENTS
Material Type:
Article
Add to My Research

BIOM-06. IDENTIFICATION OF AN INFLAMMATORY BIOMARKER SIGNATURE IN PLASMA-DERIVED EXTRACELLULAR VESICLES OF GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii5 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.016

Full text available

19
BIOM-48. HOXD12 IS AN INDEPENDENTLY PROGNOSTIC AGE-ASSOCIATED INDICATOR FOR POOR SURVIVAL IN OLIGODENDROGLIOMA
Material Type:
Article
Add to My Research

BIOM-48. HOXD12 IS AN INDEPENDENTLY PROGNOSTIC AGE-ASSOCIATED INDICATOR FOR POOR SURVIVAL IN OLIGODENDROGLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii15 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.058

Full text available

20
BIOM-03. COMPREHENSIVE GENOMIC AND IMMUNE PROFILING OF NON-SMALL CELL LUNG CANCER BRAIN METASTASES REVEALS LOW TUMOR INFLAMMATION AND ELEVATED CANCER TESTIS ANTIGEN BURDEN
Material Type:
Article
Add to My Research

BIOM-03. COMPREHENSIVE GENOMIC AND IMMUNE PROFILING OF NON-SMALL CELL LUNG CANCER BRAIN METASTASES REVEALS LOW TUMOR INFLAMMATION AND ELEVATED CANCER TESTIS ANTIGEN BURDEN

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii4-vii4 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.013

Full text available

Results 1 - 20 of 456,991  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (414,527)

Refine My Results

Creation Date 

From To
  1. Before 1965  (26)
  2. 1965 To 1984  (75)
  3. 1985 To 1997  (17,095)
  4. 1998 To 2011  (104,883)
  5. After 2011  (334,785)
  6. More options open sub menu

Subject 

  1. Science & Technology  (389,251)
  2. Life Sciences & Biomedicine  (354,054)
  3. Humans  (292,646)
  4. Biomarkers  (230,053)
  5. Female  (174,428)
  6. Male  (158,280)
  7. Middle Aged  (118,781)
  8. Adult  (96,356)
  9. Aged  (91,173)
  10. Oncology  (77,186)
  11. Biomarkers - Blood  (72,603)
  12. Prognosis  (70,702)
  13. Animals  (64,975)
  14. Biological And Medical Sciences  (57,079)
  15. Tumors  (52,199)
  16. Proteins  (50,282)
  17. Patients  (49,647)
  18. Medical Sciences  (49,124)
  19. Gene Expression  (46,813)
  20. Risk Factors  (45,315)
  21. More options open sub menu

Language 

  1. English  (450,640)
  2. Japanese  (62,401)
  3. Portuguese  (3,163)
  4. Spanish  (1,775)
  5. German  (1,712)
  6. French  (1,229)
  7. Chinese  (823)
  8. Russian  (652)
  9. Norwegian  (646)
  10. Polish  (475)
  11. Korean  (353)
  12. Italian  (263)
  13. Turkish  (255)
  14. Swedish  (204)
  15. Czech  (90)
  16. Dutch  (77)
  17. Serbian  (76)
  18. Persian  (72)
  19. Ukrainian  (66)
  20. Croatian  (62)
  21. More options open sub menu

Searching Remote Databases, Please Wait